Jones Financial Companies’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93K Sell
919
-800
-47% -$4.83K ﹤0.01% 4099
2026
Q1
$10.8K Buy
1,719
+1,250
+267% +$10.4K ﹤0.01% 3552
2025
Q4
$4.89K Hold
469
﹤0.01% 3512
2025
Q3
$4.24K Sell
469
-1,700
-78% -$14.9K ﹤0.01% 3417
2025
Q2
$27.5K Buy
2,169
+150
+7% +$2.25K ﹤0.01% 2460
2025
Q1
$53.6K Buy
2,019
+19
+1% +$565 ﹤0.01% 2032
2024
Q4
$68.8K Hold
2,000
﹤0.01% 1767
2024
Q3
$97.1K Buy
+2,000
New +$102K ﹤0.01% 1417

Other funds holding RXST

Jones Financial Companies's RXST Position: Q2 2026 in Review

Jones Financial Companies reduced its RxSight (RXST) stake by 47% in Q2 2026, selling an estimated $4.83K and leaving 919 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #4099.

Jones Financial Companies first reported a position in RXST in Q3 2024 and has held it in 8 quarters since. The position peaked at $97.1K in Q3 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Jones Financial Companies held 919 shares of RxSight worth $4.93K as of Q2 2026.
  • Jones Financial Companies sold 800 RxSight shares in Q2 2026, an estimated $4.83K.
  • RxSight made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4099 holding.
  • Jones Financial Companies first reported a position in RxSight in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's RxSight position peaked at $97.1K in Q3 2024.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.